SABCS HER2-Negative Spotlight
A spotlight on HER2-negative breast cancer from the 2016 San Antonio Breast Cancer Symposium (SABCS) at the Henry B. Gonzalez Convention Center in San Antonio, Texas, from December 6 to December 10, 2016.
Ongoing Trial of Abemaciclib and Pembrolizumab in HR+/HER2-Negative Breast Cancer
Maura N. Dickler, MD
Encouraging Findings With Ribociclib in HR+ Breast Cancer
Harold J. Burstein, MD, PhD